Navigation Links
Inverness Medical Innovations Announces Second Quarter 2008 Results
Date:7/29/2008

s and

Reconciliation to Non-GAAP Adjusted Cash Basis Amounts

(in $000s, except per share amounts)

Three Months Ended June 30, 2008

Non-GAAP

Adjusted

Non-GAAP Cash

GAAP Adjustments Basis (a)

Net revenue $401,127 $- $401,127

Cost of revenue 195,025 (17,225)(b)(c)(d)(e) 177,800

Gross profit 206,102 17,225 223,327

Gross margin 51% 56%

Operating expenses:

Research and development 29,808 (5,313)(b)(c)(d) 24,495

Selling, general and

administrative 172,792 (50,794)(b)(c)(d) 121,998

Total operating expenses 202,600 (56,107) 146,493

Operating income (loss) 3,502 73,332 76,834

Interest and other income

(expense), net (38,646) 6,624 (c) (32,022)

Income tax (benefit) provision (7,698) 23,066 (h) 15,368

Equity earnings of

unconsolidated entities,

net of tax (2,902) 6,199 (b)(c) 3,297

Net (loss) income $(30,348) $63,089 $32,741

Preferred stock dividends $(3,107) $(3,107)

Net (loss) income

available to common

stockholders - basic $(33,455) $29,634

Net (loss) income per

common share

Basic $(0.43) $0.38

Diluted $(0.43)(i)
'/>"/>

SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Inverness Medical Innovations Agrees to Acquire Panbio Ltd.
2. Inverness - Chemogen Establish Exclusive License for TB Antibodies
3. Inverness Medical Innovations Announces Proposed Public Offering of Common Stock
4. Inverness Medical Innovations Agrees to Acquire ParadigmHealth
5. Inverness Medical Innovations Acquires ParadigmHealth
6. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 2008
7. Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
8. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
9. Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc
10. Inverness Medical Innovations Announces Fourth Quarter 2007 Results
11. Inverness Medical Innovations to Participate at Bank of America 2008 Smid Cap Conference on March 26, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Md., July 29, 2014  United Therapeutics Corporation ... its financial results for the second quarter ... growth shows that our medicines are reaching ... arterial hypertension (PAH)," said Martine Rothblatt, Ph.D., ... "The commercial launch this quarter of our ...
(Date:7/29/2014)... San Diego, CA (PRWEB) July 29, 2014 ... added to Pipette.com’s centrifugation product selection. Eppendorf 5427 R ... reverse engineering, and DNA – it is targeted towards ... the Eppendorf Centrifuge 5427 R as it compliments their ... as their Eppendorf line of microcentrifuge tubes, PCR tubes, ...
(Date:7/29/2014)... 2014 White papers by Clinovo ... based eClinical technologies, have been published by leading pharmaceutical ... a long line of white papers by Clinovo to ... Science Leader, Pharmaceutical Online, and OpenHealthNews. , At the ... by CTO Marc Desgrousilliers, 'The Five Essentials of ...
(Date:7/28/2014)... materials using light, developed by researchers at the University ... often considered the realm of science fiction, such as ... starships won,t be a reality for quite some time, ... with building blocks a few billionths of a metre ... light flies through them, and works on large chunks ...
Breaking Biology Technology:United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 2United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 3United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 4United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 5United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 6United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 7United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 8United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 9United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 10United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 11United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 12United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 13International Pipette Distributor, Pipette.com Announces the Addition of the Eppendorf Centrifuge 5427 R to Their Product Portfolio 2Clinovo White Papers Published in Summer 2014 Editions of Leading Medical Device & Pharmaceutical Publications 2Clinovo White Papers Published in Summer 2014 Editions of Leading Medical Device & Pharmaceutical Publications 3Building 'invisible' materials with light 2
... 2012  Avaxia Biologics, Inc., a privately-held biotech company using ... for the treatment of gastrointestinal diseases, announced today that ... Officer of Arisaph Pharmaceuticals, Inc. to its Board of ... has agreed to serve on our Board," said Dr. ...
... Europe,s premier biotech conference continues to grow and see ... network which provides comprehensive support for bioscience businesses in ... announced the results of the sixth annual BioTrinity Biopartnering ... at Newbury Racecourse, UK, BioTrinity is now firmly established ...
... IRVINE, Calif., April 25, 2012 Aviir Diagnostic ... a contractual agreement with MultiPlan, Inc. for ancillary ... in the MultiPlan, PHCS and PHCS Savility Networks. ... cardiologists and scientists from the Stanford University School ...
Cached Biology Technology:Avaxia Biologics Elects Christopher Kiritsy to its Board of Directors 2Another Record Year for BioTrinity 2Another Record Year for BioTrinity 3Aviir Laboratories Announce National Agreement With MultiPlan 2
(Date:7/29/2014)... different types of cell, including sperm, bacteria and ... flagella. These protrusions, about one-hundredth of a millimetre ... through fluid. Similar, shorter structures called cilia are ... they perform roles such as moving liquids over ... remarkably versatile: they transport mucus and expel pathogens ...
(Date:7/28/2014)... 100 drugs already approved by the U.S. Food and ... the growth of certain bacterial pathogens inside human cells, ... spotted fever. The findings, published in mBio , ... Microbiology, demonstrate a new way of identifying non-antibiotic drugs ... , A handful of drugs on the list inhibit ...
(Date:7/28/2014)... Norwegian explorer Roald Amundsen reached the South Pole in ... arrived long before any human. , Using data from ... the Antarctic continent, including the South Pole, a group ... (DRI) in Reno, Nevada, created the most accurate and ... southernmost continent. The new record, described in an article ...
Breaking Biology News(10 mins):Microscopic rowing -- without a cox 2Microscopic rowing -- without a cox 3New route to identify drugs that can fight bacterial infections 2Lead pollution beat explorers to South Pole, persists today 2Lead pollution beat explorers to South Pole, persists today 3
... Oct. 25, 2012 /PRNewswire-iReach/ -- New research shows that ... Maine have demonstrated improvements in health behaviors that persisted ... and rising health care costs continue to challenge employers, ... to reduce health risks and improve health behaviors. ...
... provide the ideal petri dish for cultivating bioscience with ... so, given the opportunity to translate public funding into ... by UCSF researchers. In an analysis published Oct. ... at the California Institute for Quantitative Biosciences (QB3) assessed ...
... Risks of Overfishing," published today in the journal ... the Institute for Ocean Conservation Science and professor at ... According to Dr. Pikitch, current and recent studies demonstrate ... management, in which fishing is restricted to those places ...
Cached Biology News:New Study Shows That Improvements in Employee Health Behaviors Persist Over Two Years 2Academia should fulfill social contract by supporting bioscience startups, case study says 2Academia should fulfill social contract by supporting bioscience startups, case study says 3Traditional fisheries management approach jeopardizes marine ecosystems worldwide 2
CleanBox DNA workstation with two 254nm UV lambs & 12-hr timer, 90cm (36-inch)width, single door, 115V (w/crating)...
Mouse polyclonal antibody raised against a partial recombinant DDEF2. NCBI Entrez Gene ID = 8853...
Mouse polyclonal antibody to BAG2 - BCL2-associated athanogene 2...
... are multi-functional mixing devices. Stepping motors device ... solid, heavy-duty durable shaker to provide a ... vortexing in nature. Regulated action scale for ... display to control time, continuous time, action ...
Biology Products: